THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2019
Price : $35 *
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms THAWS
- 13 Mar 2019 Status changed from active, no longer recruiting to completed.
- 11 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Nov 2017 Planned end date changed to 31 Mar 2020.